A detailed history of Concord Wealth Partners transactions in Quanterix Corp stock. As of the latest transaction made, Concord Wealth Partners holds 100 shares of QTRX stock, worth $1,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$1,321
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$8.75 - $14.02 $875 - $1,402
100 New
100 $1,000
Q4 2021

Jan 21, 2022

BUY
$37.54 - $57.51 $3,754 - $5,751
100 New
100 $4,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $489M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.